Wojcik, G; Sahu-Osen, A; Gindlhuber, J; Hutami Syarif, A; Birnhuber, A; Hoffmann, J; Mischkulnig, L; Bonyadi Rad, E; Wygrecka, M; Hoetzenecker, K; Evermann, M; Olschewski, A; Kersten, S; Bellusci, S; Marsh, L; Agha, E; Vesely, P; Kwapiszewska, G; Biasin, V
COLLAGEN VS LIPIDS: THE LUNG FIBROSIS STORY.
22nd International Colloquium on Lung and Airway Fibrosis, ICLAF 2024,; OCT 12-16, 2024; Athens, GREECE. 2024.
[Poster]
[Science to Public]
Biasin, V; Sahu-Osen, A; Wojcik, G; Wygrecka, M; Hoffmann, J; Kersten, S; Mischkulnig, L; Bonyadirad, E; Veseley, P; Crnkovic, S; Hoetzenecker, K; Bohm, P; Bellusci, S; Marsh, LM; El Agha, E; Kwapiszewska, G
Loss of ANGPTL4 locks the lipofibroblast phenotype and attenuates lung fibrosis.
Doctoral Day 2023; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Wojcik,G; Sahu-Osen, A; Gindlhuber, J; Syarif, A; Wygrecka, M; Birnhuber, A; Hoffmann, J; Mischkulnig, L; Bonyadirad, E; Kersten, S; Hoetzenecker, K; Bohm, P; Olschewski, A; Vesely, P; Crnkovic, S; Bellusci, S; Marsh, LM; El Agha, E; Kwapiszewska, G; Biasin, V
Lipids Unveiled: Exploring their Role in Pulmonary Fibrosis
The progression of Idiopathic Pulmonary Fibrosis (IPF) relies heavily on the overproduction of collagen and alterations in fatty acid (FA) metabolism. We propose that changes in lipid metabolism, driven by the actions of Angiopoietin-like 4 (ANGPTL4), may also have a significant impact on the activity of lung fibroblasts (PDGFRα+ cells), ultimately affecting the progression of lung fibrosis.
. 2023; -7TH LUNG DAYS - 7. GRAZER LUNGENTAGE; NOV 23-24, 2023; Graz, AUSTRIA.
[Poster]
Wojcik, G; Biasin, V; Crnkovic, S; Sahu-Osen, A; Wygrecka, M; Hoffmann, J; Kersten, S; Mischkuling, L; Bonyadirad, B; Veseley, P; Hoetzenecker, K; Bohm, P; Bellusci, S; Marsh, LM; El Agha, E; Kwapiszewska, G
Loss of ANGPTL4 locks the lipofibroblast phenotype and attenuates lung fibrosis
8th International Graz Symposium on Lipid and Membrane Biology; APR 21-23, 2022; Graz, AUSTRIA. 2022.
[Poster]
FullText
Mutgan, AC; Jandl, K; Marsh, L; Hoffmann, J; Gschwandtner, E; Klepetko, W; Heinemann, A; Olschewski, H; Olschewski, A; Wygrecka, M; Kwapiszewska, G
Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction
EUR RESPIR J. ERS International Congress 2021 abstracts. 2021; 58: -ERS International Congress; SEP 5-8, 2021; Virtuell.
Doi: 10.1183/13993003.congress-2021.PA594
[Poster]
Web of Science
FullText
FullText_MUG
Jandl, K; Marsh, LM; Hoffmann, J; Mutgan, AC; Baum, O; Bloch, W; Sinn, K; Klepetko, W; Heinemann, A; Olschewski, A; Olschewski, H; Kwapiszewska, G
Basement membrane, a specialized extracellular matrix, shapes endothelial function in IPAH.
EUR RESPIR J. 2020; 56:
Doi: 10.1183/13993003.congress-2020.1488
[Poster]
Web of Science
FullText
FullText_MUG
Mutgan, AC; Jandl, K; Hoffmann, J; Klepetko, W; Kovacs, G; Olschewski, H; Olschewski, A; Kwapiszewska, G
Fragment of Collagen IV is a mediator of endothelial dysfunction in pulmonary hypertension
WIEN KLIN WOCHENSCHR. 2019; 131(19-20):511-511.
[Oral Communication]
Web of Science
Jandl, K; Marsh, L; Hoffmann, J; Bloch, W; Sinn, K; Klepetko, W; Kovac, G; Olschewski, A; Olschewski, H; Kwapiszewska, G
Basement membrane remodelling defines the progression of IPAH: the role of Collagen XVIIIA1*
WIEN KLIN WOCHENSCHR. 2018; 130(19-20):604-604.
[Oral Communication]
Web of Science
Orthmann, A; Krassnig, S; Jodicke, A; Linnebacher, M; Silvestri, A; Regenbrecht, C; Fichtner, I; Hoffmann, J
New preclinical models for neuro-oncology: Integrating data from PD3D models and orthotopic xenografts
ONCOL RES TREAT. 2018; 41: 179-179.-Deutscher Krebskongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kammerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J
Eukaryotic translation initiation factors impact non small cell lung cancer
VIRCHOWS ARCH. 2017; 471: S104-S104.
[Poster]
Web of Science
Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Reinhard, C; Popper, H; Sattler, W; Haybaeck, J.
Eukaryotic Translation Initiation Factors trigger Non Small Cell Lung Cancer (NSCLC)
International Student Congress; May 25-27, 2017; Graz. 2017.
[Oral Communication]
Gantenbein, N; Bernhart, E; Anders, I; Lindenmann, J; Fink-Neubock, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Reinhard, C; Popper, H; Sattler, W; Haybaeck, J
Eukaryotic Translation Initiation Factors Impact Non-Small Cell Lung Cancer
J THORAC ONCOL. 2017; 12(1):S1141-S1142.
Doi: 10.1016/j.jtho.2016.11.1602
[Poster]
Web of Science
FullText
FullText_MUG
Golob-Schwarzl, N; Koller, C; Krassnig, S; Gogg-Kammerer, M; Gantenbein, N; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation initiation separates low and high grade and colon and rectum carcinoma
VIRCHOWS ARCH. 2017; 471: S167-S167.
[Poster]
Web of Science
Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46.
[Oral Communication]
Web of Science
Puthenparampil, HT; Jandl, K; Wilhelm, J; Hoffmann, J; Marsh, L; Klepetko, W; Olschewski, A; Brock, M; Kwapiszewska, G
Differentially expressed lncRNAs in IPAH: the impact of PAXIP1-AS1 on hPASMCs function
WIEN KLIN WOCHENSCHR. .. 2017; 129(19-20):755-755.
[Poster]
Web of Science
Hoffmann, J; Ghanim, B; Klepetko, W; Kovacs, G; Olschewski, H; Olschewski, A; Kwapiszewska, G
Composition And Structure Of The Vascular Basement Membrane In Pulmonary Hypertension
AM J RESP CRIT CARE. .. 2016; 193: -International Conference of the American-Thoracic-Society (ATS); MAY 13-18, 2016; San Francisco, CA.
[Poster]
Web of Science
Jandl, K; Hoffmann, J; Bloch, Thekkekara Puthenparampil, H; W; Ghanim, B; Klepetko, W; Kovacs, G; Olschewski, H; Olschewski, A; Kwapiszewska, G
Endostatin – a biomarker for idiopathic pulmonary arterial hypertension?
DACH Herbstsymposium für Pulmonale Hypertonie; NOV 24-26, 2016; Heidelberg, GERMANY. 2016.
[Poster]
Jandl, K; Hoffmann, J; Bloch, W; Ghanim, B; Klepetko, W; Kovacs, G; Olschewski, H; Olschewski, A; Kwapiszewska, G
Disturbances in composition, structure and function of the vascular basement membrane in pulmonary hypertension
WIEN KLIN WOCHENSCHR. 2016; 128(19-20):761-761.
[Oral Communication]
Web of Science
Jandl, K; Hoffmann, J; Ghanim, B; Klepetko, W; Kovacs, G; Bloch, W; Olschewski, H; Olschewski, A; Kwapiszewska, G;
Distinct structure and composition of the vascular basement membrane in pulmonary hypertension.
MBE 2016. 2016; -Matrix Biology Europe Conference; JUNE 11-14, 2016; Athens, GREECE.
[Poster]
Orthmann, A; Hayback, J; Jodicke, A; Kuhn, S; Linnebacher, M; Fichtner, I; Hoffmann, J
New preclinical models for neuro-oncology: Orthotopic patient derived glioblastoma xenografts in mice
EUR J CANCER. 2016; 68: S52-S52.
Doi: 10.1016/S0959-8049(16)32741-1
[Poster]
Web of Science
FullText
FullText_MUG
Orthmann, A; Hoffmann, A; Ernst, C; Golob-Schwarzl, N; Krassnig, S; Haybaeck, J; Jodicke, A; Kuhn, S; Linnebacher, M; Fichtner, I; Hoffmann, J
Therapeutic response to chemotherapeutic drugs of glioma-PDX and correlation to common mutations identified by panel sequencing
ONCOL RES TREAT. 2016; 39: 160-160.
[Oral Communication]
Web of Science
Anders, I; Asslaber, M; Golob-Schwarzl, N; Halbwedl, I; Gogg-Kamerer, M; Al-Effah, M; Hoffmann, J; Rolff, J; Popper, H; Haybaeck, J
Particular components of the translation machinery drive lung cancer formation
VIRCHOWS ARCH. 2015; 467: S258-S258.
[Poster]
Web of Science
Ernst, C; Krassnig, S; Golob-Schwarzl, N; Asslaber, M; Raicht, A; Lederer, E; Spilka, R; Von Campe, G; Orthmann, A; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors and their contribution to gliomas might be relevant for the development of new therapies
VIRCHOWS ARCH. . 2015; 467: S40-S40.
[Oral Communication]
Web of Science
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, C; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Hoyle, N; Reinhard, C; Lax, S; Haybaeck, J
Eukaryotic translation initiation factors are overexpressed in colorectal carcinoma compared to -normal colorectalmucosa: Impact on the RTK/PI3K/Akt-mTOR pathway and putative therapeutic targets
VIRCHOWS ARCH. 2015; 467: S8-S8.
[Oral Communication]
Web of Science
Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, C; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Hoyle, N; Reinhard, C; Lax, S; Haybaeck, J
Modulation of eukaryotic translation initiation factor expression in colorectal carcinoma by cytostatic and targeted medication as demonstrated in xenograft models
VIRCHOWS ARCH. 2015; 467: S166-S166.
[Poster]
Web of Science
Lederer, E; Petzold, J; Rehis, R; Ernst, C; Bettermann, K; Golob-Schwarzl, N; Moriggl, R; Schlederer, M; Lax, S; Hoffmann, J; Haybaek, J
The role of the JAK/STAT pathway in gallbladder cancer
VIRCHOWS ARCH. 2015; 467: S3-S3.
[Oral Communication]
Web of Science
Marsh, L; Hoffmann, J; Ghanim, B; Klepetko, W; Olschewski, H; Olschewski, A; Kwapiszewska, G
Diverse Forms Of Pulmonary Hypertension Possess Distinct Inflammatory Cell Profiles
AM J RESP CRIT CARE. 2015; 191: -International Conference of the American-Thoracic-Society (ATS); MAY 15-20, 2015; Denver, CO.
[Oral Communication]
Web of Science
Marsh, LM; Stacher, E; Hoffmann, J; Ghanim, B; Klepetko, W; Olschewski, H; Olschewski, A; Kwapiszewska, G
Inflammatory profiling of chronic lung disease with associated pulmonary hypertension
WIEN KLIN WOCHENSCHR. 2015; 127(19-20):820-820.
[Oral Communication]
Web of Science
Foris, V; Kovacs, G; Avian, A; Douschan, P; Tscherner, M; Kwapiszewska, G; Crnkovic, S; Hoffmann, J; Ghanim, B; Klepetko, W; Olschewski, A; Olschewski, H
A Comprehensive Approach For Biomarker Assessment In Pulmonary Hypertension.
2014: A3853, 10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3853. 2014; -American Thoracic Society; May 16-21, 2014; San Diego, USA.
[Poster]
FullText
Hoffmann, J; Wilhelm, J; Marsh, LM; Ghanim, B; Klepetko, W; Kovacs, G; Olschewski, H; Olschewski, A; Kwapiszewska, G
Differential gene expression pattern in pulmonary artery profiles of COPD and IPF patients with pulmonary hypertension
WIEN KLIN WOCHENSCHR. 2014; 126(19-20):677-678.-Austrian Society of Pneumology; Oct 2-4 2014; Salzburg.
[Oral Communication]
Web of Science
Hoffmann, J; Wilhelm, J; Marsh, LM; Ghanim, B; Klepetko, W; Kovacs, G; Olschewski, H; Olschewski, A; Kwapiszewska, G
Distinct Gene Expression Pattern In Pulmonary Artery Profiles Of PH-Associated COPD And IPF Patients
Am J Respir Crit Care Med. 2014; 189: A1881-A1881.-American Thoracic Society; May 16-21, 2014; San Diego, USA.
[Poster]